The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort

Betancor, Diana; Villalobos-Vilda, Carlos; Olaguibel, José María; Rodrigo-Muñoz, José Manuel; Alvarez Puebla, María Jose; Arismendi, Ebymar; Barranco, Pilar; Barroso, Blanca; Bobolea, Irina; Cárdaba, Blanca.
Arch. bronconeumol. (Ed. impr.) ; 59(9)sep. 2023. tab
Artículo en Inglés | IBECS (España) | ID: ibc-225008

Documentos relacionados

  1. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV<sub>1</sub> - a post-hoc analysis of pooled data.
  2. New Guidelines for Bronchodilator Responsiveness in COPD: A Test in Search of a Use.
  3. A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values.
  4. Which patients with COPD need an inhaled corticosteroid?
  5. Pharmacology and Therapeutics of Bronchodilators Revisited.
  6. Correlation between impulse oscillometry with bronchodilator reversibility in asthmatic population in a tertiary referral centre.
  7. Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
  8. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.
  9. Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3.
  10. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.